Back to Results
First PageMeta Content
Organic chemistry / Selective serotonin reuptake inhibitors / Psychiatry / Eli Lilly and Company / Organofluorides / Obsessive–compulsive disorder / Psilocybin / Lysergic acid diethylamide / Hallucinogen / Entheogens / Chemistry / Novartis


Moreno et al. Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder Francisco A. Moreno, M.D.; Christopher B. Wiegand, M.D.; E. Keolani Taitano, Ph.D.; and Pedro L. Delgado, M
Add to Reading List

Document Date: 2014-10-08 15:35:57


Open Document

File Size: 105,76 KB

Share Result on Facebook
UPDATE